Geographic variation of mutagenic exposures in kidney cancer genomes.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
01 May 2024
Historique:
received: 04 05 2023
accepted: 28 03 2024
medline: 2 5 2024
pubmed: 2 5 2024
entrez: 1 5 2024
Statut: aheadofprint

Résumé

International differences in the incidence of many cancer types indicate the existence of carcinogen exposures that have not yet been identified by conventional epidemiology make a substantial contribution to cancer burden

Identifiants

pubmed: 38693263
doi: 10.1038/s41586-024-07368-2
pii: 10.1038/s41586-024-07368-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. The Author(s).

Références

Brennan, P. & Davey-Smith, G. Identifying novel causes of cancers to enhance cancer prevention: new strategies are needed. J. Natl Cancer Inst. 114, 353–360 (2022).
pubmed: 34743211 doi: 10.1093/jnci/djab204
Hsieh, J. J. et al. Renal cell carcinoma. Nat. Rev. Dis. Primers 3, 17009 (2017).
pubmed: 28276433 pmcid: 5936048 doi: 10.1038/nrdp.2017.9
Koh, G., Degasperi, A., Zou, X., Momen, S. & Nik-Zainal, S. Mutational signatures: emerging concepts, caveats and clinical applications. Nat. Rev. Cancer 21, 619–637 (2021).
pubmed: 34316057 doi: 10.1038/s41568-021-00377-7
Alexandrov, L. B. et al. The repertoire of mutational signatures in human cancer. Nature 578, 94–101 (2020).
pubmed: 32025018 pmcid: 7054213 doi: 10.1038/s41586-020-1943-3
Scelo, G. et al. Variation in genomic landscape of clear cell renal cell carcinoma across Europe. Nat. Commun. 5, 5135 (2014).
pubmed: 25351205 doi: 10.1038/ncomms6135
Mitchell, T. J. et al. Timing the landmark events in the evolution of clear cell renal cell cancer: TRACERx renal. Cell 173, 611–623.e17 (2018).
pubmed: 29656891 pmcid: 5927631 doi: 10.1016/j.cell.2018.02.020
Campbell, P. J. et al. Pan-cancer analysis of whole genomes. Nature 578, 82–93 (2020).
doi: 10.1038/s41586-020-1969-6
Degasperi, A. et al. A practical framework and online tool for mutational signature analyses show intertissue variation and driver dependencies. Nat. Cancer 1, 249–263 (2020).
pubmed: 32118208 pmcid: 7048622 doi: 10.1038/s43018-020-0027-5
The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499, 43–49 (2013).
pmcid: 3771322 doi: 10.1038/nature12222
Mutographs. Cancer Grand Challenges https://cancergrandchallenges.org/teams (2023).
Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA 71, 209–249 (2021).
pubmed: 33538338
Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979–993 (2012).
pubmed: 22608084 pmcid: 3414841 doi: 10.1016/j.cell.2012.04.024
Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).
pubmed: 23945592 pmcid: 3776390 doi: 10.1038/nature12477
Drost, J. et al. Use of CRISPR-modified human stem cell organoids to study the origin of mutational signatures in cancer. Science 358, 234–238 (2017).
pubmed: 28912133 pmcid: 6038908 doi: 10.1126/science.aao3130
Hoang, M. L. et al. Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Sci. Transl. Med. 5, 197ra102 (2013).
pubmed: 23926200 pmcid: 3973132 doi: 10.1126/scitranslmed.3006200
Poon, S. L. et al. Genome-wide mutational signatures of aristolochic acid and its application as a screening tool. Sci. Transl. Med. 5, 197ra101 (2013).
pubmed: 23926199 doi: 10.1126/scitranslmed.3006086
Grollman, A. P. Aristolochic acid nephropathy: harbinger of a global iatrogenic disease. Environ. Mol. Mutagen. 54, 1–7 (2013).
pubmed: 23238808 doi: 10.1002/em.21756
Turesky, R. J. et al. Aristolochic acid exposure in Romania and implications for renal cell carcinoma. Br. J. Cancer 114, 76–80 (2016).
pubmed: 26657656 doi: 10.1038/bjc.2015.402
Wang, X.-M. et al. Integrative genomic study of Chinese clear cell renal cell carcinoma reveals features associated with thrombus. Nat. Commun. 11, 739 (2020).
pubmed: 32029730 pmcid: 7005298 doi: 10.1038/s41467-020-14601-9
Stefanovic, V. & Radovanovic, Z. Balkan endemic nephropathy and associated urothelial cancer. Nat. Clin. Pract. Urol. 5, 105–112 (2008).
pubmed: 18259188 doi: 10.1038/ncpuro1019
Huang, M. N. et al. Genome-scale mutational signatures of aflatoxin in cells, mice, and human tumors. Genome Res. 27, 1475–1486 (2017).
pubmed: 28739859 pmcid: 5580708 doi: 10.1101/gr.220038.116
Haradhvala, N. J. et al. Mutational strand asymmetries in cancer genomes reveal mechanisms of DNA damage and repair. Cell 164, 538–549 (2016).
pubmed: 26806129 pmcid: 4753048 doi: 10.1016/j.cell.2015.12.050
Otlu, B. et al. Topography of mutational signatures in human cancer. Cell Rep. 42, 112930 (2023).
pubmed: 37540596 pmcid: 10507738 doi: 10.1016/j.celrep.2023.112930
Nik-Zainal, S. The genome as a record of environmental exposure. Mutagenesis 30, 763–770 (2015).
pubmed: 26443852 pmcid: 4637815
Sato, Y. et al. Integrated molecular analysis of clear-cell renal cell carcinoma. Nat. Genet. 45, 860–867 (2013).
pubmed: 23797736 doi: 10.1038/ng.2699
Dempsey, D. et al. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin. Pharmacol. Ther. 76, 64–72 (2004).
pubmed: 15229465 doi: 10.1016/j.clpt.2004.02.011
Velenosi, T. J. et al. Untargeted metabolomics reveals N,N,N-trimethyl-L-alanyl-L-proline betaine (TMAP) as a novel biomarker of kidney function. Sci. Rep. 9, 6831 (2019).
pubmed: 31048706 pmcid: 6497643 doi: 10.1038/s41598-019-42992-3
Nik-Zainal, S. et al. The life history of 21 breast cancers. Cell 149, 994–1007 (2012).
pubmed: 22608083 pmcid: 3428864 doi: 10.1016/j.cell.2012.04.023
Dentro, S. C., Wedge, D. C. & van Loo, P. Principles of reconstructing the subclonal architecture of cancers. Cold Spring Harb. Perspect. Med. 7, a026625 (2017).
pubmed: 28270531 pmcid: 5538405 doi: 10.1101/cshperspect.a026625
Shearer, J. J. et al. Serum concentrations of per- and polyfluoroalkyl substances and risk of renal cell carcinoma. J. Natl Cancer Inst. 113, 580–587 (2021).
pubmed: 32944748 doi: 10.1093/jnci/djaa143
Kucab, J. E. et al. A compendium of mutational signatures of environmental agents. Cell 177, 821–836.e16 (2019).
pubmed: 30982602 pmcid: 6506336 doi: 10.1016/j.cell.2019.03.001
Gabriel, A. A. G. et al. Genetic analysis of lung cancer and the germline impact on somatic mutation burden. J. Natl Cancer Inst. 114, 1159–1166 (2022).
pubmed: 35511172 pmcid: 9360465 doi: 10.1093/jnci/djac087
Liu, Y., Gusev, A., Heng, Y. J., Alexandrov, L. B. & Kraft, P. Somatic mutational profiles and germline polygenic risk scores in human cancer. Genome Med. 14, 14 (2022).
pubmed: 35144655 pmcid: 8832866 doi: 10.1186/s13073-022-01016-y
Moody, S. et al. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat. Genet. 53, 1553–1563 (2021).
pubmed: 34663923 doi: 10.1038/s41588-021-00928-6
Abascal, F. et al. Somatic mutation landscapes at single-molecule resolution. Nature 593, 405–410 (2021).
pubmed: 33911282 doi: 10.1038/s41586-021-03477-4
Robinson, P. S. et al. Increased somatic mutation burdens in normal human cells due to defective DNA polymerases. Nat. Genet. 53, 1434–1442 (2021).
pubmed: 34594041 pmcid: 8492474 doi: 10.1038/s41588-021-00930-y
Robinson, P. S. et al. Inherited MUTYH mutations cause elevated somatic mutation rates and distinctive mutational signatures in normal human cells. Nat. Commun. 13, 3949 (2022).
pubmed: 35803914 pmcid: 9270427 doi: 10.1038/s41467-022-31341-0
Fowler, J. C. & Jones, P. H. Somatic mutation: what shapes the mutational landscape of normal epithelia? Cancer Discov. 12, 1642–1655 (2022).
pubmed: 35397477 pmcid: 7613026 doi: 10.1158/2159-8290.CD-22-0145
Whalley, J. P. et al. Framework for quality assessment of whole genome cancer sequences. Nat. Commun. 11, 5040 (2020).
pubmed: 33028839 pmcid: 7541455 doi: 10.1038/s41467-020-18688-y
Bergmann, E. A., Chen, B.-J., Arora, K., Vacic, V. & Zody, M. C. Conpair: concordance and contamination estimator for matched tumor–normal pairs. Bioinformatics 32, 3196–3198 (2016).
pubmed: 27354699 pmcid: 5048070 doi: 10.1093/bioinformatics/btw389
Van Loo, P. et al. Allele-specific copy number analysis of tumors. Proc. Natl Acad. Sci. USA 107, 16910–16915 (2010).
pubmed: 20837533 pmcid: 2947907 doi: 10.1073/pnas.1009843107
Jones, D. et al. cgpCaVEManWrapper: simple execution of CaVEMan in order to detect somatic single nucleotide variants in NGS data. Curr. Protoc. Bioinform. 56, 15.10.1–15.10.18 (2016).
doi: 10.1002/cpbi.20
Raine, K. M. et al. cgpPindel: identifying somatically acquired insertion and deletion events from paired end sequencing. Curr. Protoc. Bioinform. 52, 15.7.1–15.7.12 (2015).
doi: 10.1002/0471250953.bi1507s52
Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591–594 (2018).
pubmed: 30013048 doi: 10.1038/s41592-018-0051-x
Bergstrom, E. N. et al. SigProfilerMatrixGenerator: a tool for visualizing and exploring patterns of small mutational events. BMC Genom. 20, 685 (2019).
doi: 10.1186/s12864-019-6041-2
Liu, M., Wu, Y., Jiang, N., Boot, A. & Rozen, S. G. mSigHdp: hierarchical Dirichlet process mixture modeling for mutational signature discovery. NAR Genom. Bioinform. 5, lqad005 (2023).
pubmed: 36694663 pmcid: 9869330 doi: 10.1093/nargab/lqad005
Islam, S. M. A. et al. Uncovering novel mutational signatures by de novo extraction with SigProfilerExtractor. Cell Genom. 2, 100179 (2022).
pubmed: 36388765 pmcid: 9646490 doi: 10.1016/j.xgen.2022.100179
Senkin, S. MSA: reproducible mutational signature attribution with confidence based on simulations. BMC Bioinform. 22, 540 (2021).
doi: 10.1186/s12859-021-04450-8
Martincorena, I. et al. Universal patterns of selection in cancer and somatic tissues. Cell 171, 1029–1041.e21 (2017).
pubmed: 29056346 pmcid: 5720395 doi: 10.1016/j.cell.2017.09.042
Tamborero, D. et al. Cancer Genome Interpreter annotates the biological and clinical relevance of tumor alterations. Genome Med. 10, 25 (2018).
pubmed: 29592813 pmcid: 5875005 doi: 10.1186/s13073-018-0531-8
Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci. Signal. 6, pl1 (2013).
pubmed: 23550210 pmcid: 4160307 doi: 10.1126/scisignal.2004088
Díaz-Gay, M. et al. Assigning mutational signatures to individual samples and individual somatic mutations with SigProfilerAssignment. Bioinformatics 39, btad756 (2023).
pubmed: 38096571 pmcid: 10746860 doi: 10.1093/bioinformatics/btad756
Wilcoxon, F. Individual comparisons by ranking methods. Biometrics Bull. 1, 80 (1945).
doi: 10.2307/3001968
Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289–300 (1995).
doi: 10.1111/j.2517-6161.1995.tb02031.x
Dušek, L. et al. Epidemiology of Malignant Tumours in the Czech Republic, Version 7.0. Masaryk University http://www.svod.cz (2007).
Liu, M. et al. Association studies of up to 1.2 million individuals yield new insights into the genetic etiology of tobacco and alcohol use. Nat. Genet. 51, 237–244 (2019).
pubmed: 30643251 pmcid: 6358542 doi: 10.1038/s41588-018-0307-5
Yengo, L. et al. Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry. Hum. Mol. Genet. 27, 3641–3649 (2018).
pubmed: 30124842 pmcid: 6488973 doi: 10.1093/hmg/ddy271
Lagou, V. et al. Sex-dimorphic genetic effects and novel loci for fasting glucose and insulin variability. Nat. Commun. 12, 24 (2021).
pubmed: 33402679 pmcid: 7785747 doi: 10.1038/s41467-020-19366-9
Bycroft, C. et al. The UK Biobank resource with deep phenotyping and genomic data. Nature 562, 203–209 (2018).
pubmed: 30305743 pmcid: 6786975 doi: 10.1038/s41586-018-0579-z
Alexander, D. H., Novembre, J. & Lange, K. Fast model-based estimation of ancestry in unrelated individuals. Genome Res. 19, 1655–1664 (2009).
pubmed: 19648217 pmcid: 2752134 doi: 10.1101/gr.094052.109
Chang, C. C. et al. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience 4, 7 (2015).
pubmed: 25722852 pmcid: 4342193 doi: 10.1186/s13742-015-0047-8
Shim, H. et al. A multivariate genome-wide association analysis of 10 LDL subfractions, and their response to statin treatment, in 1868 Caucasians. PLoS ONE 10, e0120758 (2015).
pubmed: 25898129 pmcid: 4405269 doi: 10.1371/journal.pone.0120758
Choi, S. W. & O’Reilly, P. F. PRSice-2: polygenic risk score software for biobank-scale data. Gigascience 8, giz082 (2019).
pubmed: 31307061 pmcid: 6629542 doi: 10.1093/gigascience/giz082
Loftfield, E. et al. Novel biomarkers of habitual alcohol intake and associations with risk of pancreatic and liver cancers and liver disease mortality. J. Natl Cancer Inst. 113, 1542–1550 (2021).
pubmed: 34010397 pmcid: 8562969 doi: 10.1093/jnci/djab078
Gao, J., Meyer, K., Borucki, K. & Ueland, P. M. Multiplex Immuno-MALDI-TOF MS for targeted quantification of protein biomarkers and their proteoforms related to inflammation and renal dysfunction. Anal. Chem. 90, 3366–3373 (2018).
pubmed: 29420882 doi: 10.1021/acs.analchem.7b04975
R Core Team. R: A Language and Environment for Statistical Computing. https://www.r-project.org/ (R Foundation for Statistical Computing, 2022).
Van Rossum, G. & Drake, F. L. Python 3 Reference Manual (CreateSpace, 2009).
Bates, D., Mächler, M., Bolker, B. & Walker, S. Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, https://doi.org/10.18637/jss.v067.i01 (2015).
Bengtsson H. matrixStats: Functions that apply to rows and columns of matrices (and to vectors). https://cran.r-project.org/web/packages/matrixStats/index.html (2023).
Bates, D. et al. Matrix: Sparse and dense matrix classes and methods. https://matrix.r-forge.r-project.org/ (2023).
Chamberlain, S., Teucher, A. & Mahoney, M. geojsonio. https://github.com/ropensci/geojsonio (2023).
Hijmans, R. J. raster. https://github.com/rspatial/raster (2024).
Bivand, R. & Rundel, C. rgeos. https://github.com/cran/rgeos/ (2023).
Pebesma, E. & Bivand, R. Spatial Data Science: With Applications in R (Chapman and Hall/CRC, 2023).
Tennekes, M. tmaptools: Thematic map tools. https://github.com/r-tmap/tmaptools (2021).
Lin Pedersen, T. patchwork: The composer of plots. https://github.com/thomasp85/patchwork (2024).
Cheng, J. Leaflet. https://github.com/rstudio/leaflet (2023).
Wickham, H., François, R., Henry, L., Müller, K. & Vaughan, D. dplyr: A grammar of data manipulation. https://dplyr.tidyverse.org (2023).
Wickham, H., Miller, E. & Smith, D. haven: Import and export ‘SPSS’, ‘Stata’ and ‘SAS’ files. https://haven.tidyverse.org (2023).
Harrell Jr F. Hmisc: Harrell Miscellaneous. R package version 5.1-1. https://hbiostat.org/r/hmisc/ (2023).
Schauberger, P. & Walker, A. openxlsx: Read, write and edit xlsx files. https://github.com/ycphs/openxlsx (2022).
Bivand, R., Keitt, T. & Rowlingson, B. rgdal: Bindings for the ‘Geospatial’ data abstraction library. https://rgdal.r-forge.r-project.org (2023).
Wickham, H., Pedersen, T. L. & Seidel, D. scales: Scale functions for visualization. https://scales.r-lib.org (2023).
Wickham, H. stringr: Simple, consistent wrappers for common string operations. https://stringr.tidyverse.org (2023).
Wickham, H., Vaughan, D. & Girlich, M. tidyr: Tidy messy data. https://tidyr.tidyverse.org (2024).
Müller, K. & Wickham, H. tibble: Simple data frames. https://tibble.tidyverse.org/ (2023).
Dragulescu, A. & Arendt, C. xlsx: Read, write, format Excel 2007 and Excel 97/2000/XP/2003 files. https://github.com/colearendt/xlsx (2022).
Archer, E. rfPermute. https://github.com/EricArcher/rfPermute (2023).
Breiman, L. Random forests. Mach. Learn. 45, 5–32 (2001).
doi: 10.1023/A:1010933404324
Wickham, H. forcats: Tools for working with categorical variables (factors). https://forcats.tidyverse.org/ (2023).
The pandas development team. pandas-dev/pandas: Pandas. https://doi.org/10.5281/zenodo.7093122 (2022).
Harris, C. R. et al. Array programming with NumPy. Nature 585, 357–362 (2020).
pubmed: 32939066 pmcid: 7759461 doi: 10.1038/s41586-020-2649-2
Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261–272 (2020).
pubmed: 32015543 pmcid: 7056644 doi: 10.1038/s41592-019-0686-2
Seabold, S. & Perktold, J. statsmodels: Econometric and statistical modeling with Python. In 9th Python in Science Conference https://doi.org/10.25080/Majora-92bf1922-011 (2010).
Luo, J. firthlogist. https://github.com/jzluo/firthlogist (2022).
Smith, N. J. et al. pydata/patsy. https://doi.org/10.5281/zenodo.5529350 (2021).
Kluyver, T. et al. in Positioning and Power in Academic Publishing: Players, Agents and Agendas (eds Loizides, F. & Schmidt, B.) 87–90 (2016).
Wickham, H. ggplot2: Elegant graphics for data analysis. https://ggplot2.tidyverse.org (2016).
Campitelli, E. ggnewscale: Multiple fill and color scales in ggplot2. https://doi.org/10.5281/zenodo.7971612 (2023).
Mike, F. C., Davis, T. L. & ggplot2 authors. ggpattern: ‘ggplot2’ pattern geoms. https://github.com/trevorld/ggpattern (2022).
Slowikowski, K. ggrepel: Automatically position non-overlapping text labels with ‘ggplot2’. https://github.com/slowkow/ggrepel (2024).
Yutani, H. ggsflabel. https://yutannihilation.github.io/ggsflabel/ (2023).
Dunnington, D. ggspatial: Spatial data framework for ggplot2. https://paleolimbot.github.io/ggspatial/ (2023).
Kassambara, A. ggpubr: ‘ggplot2’ based publication ready plots. https://rpkgs.datanovia.com/ggpubr/ (2023).
Wilke, C. O. cowplot: Streamlined plot theme and plot annotations for ‘ggplot2’. https://wilkelab.org/cowplot/ (2024).
Hunter, J. D. Matplotlib: A 2D graphics environment. Comput. Sci. Eng. 9, 90–95 (2007).
doi: 10.1109/MCSE.2007.55
Waskom, M. L. seaborn: statistical data visualization. J. Open Source Softw. 6, 3021 (2021).
doi: 10.21105/joss.03021
He, Y. TMB_plotter. https://github.com/AlexandrovLab/TMB_plotter (2020).
Global Administrative Areas. GADM v4.1. https://gadm.org (2022).
Patterson, T. & Nathaniel, V. World Countries, 1:10 million. Natural Earth v5.1.1. https://www.naturalearthdata.com (2022).

Auteurs

Sergey Senkin (S)

Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Sarah Moody (S)

Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.

Marcos Díaz-Gay (M)

Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.

Behnoush Abedi-Ardekani (B)

Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Thomas Cattiaux (T)

Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Aida Ferreiro-Iglesias (A)

Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Jingwei Wang (J)

Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.

Stephen Fitzgerald (S)

Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.

Mariya Kazachkova (M)

Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
Biomedical Sciences Graduate Program, University of California San Diego, La Jolla, CA, USA.

Raviteja Vangara (R)

Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.

Anh Phuong Le (AP)

Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.

Erik N Bergstrom (EN)

Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.

Azhar Khandekar (A)

Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.

Burçak Otlu (B)

Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
Department of Health Informatics, Graduate School of Informatics, Middle East Technical University, Ankara, Turkey.

Saamin Cheema (S)

Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.

Calli Latimer (C)

Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.

Emily Thomas (E)

Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.

Joshua Ronald Atkins (JR)

Cancer Epidemiology Unit, The Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Karl Smith-Byrne (K)

Cancer Epidemiology Unit, The Nuffield Department of Population Health, University of Oxford, Oxford, UK.

Ricardo Cortez Cardoso Penha (R)

Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Christine Carreira (C)

Evidence Synthesis and Classification Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Priscilia Chopard (P)

Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Valérie Gaborieau (V)

Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Pekka Keski-Rahkonen (P)

Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

David Jones (D)

Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.

Jon W Teague (JW)

Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.

Sophie Ferlicot (S)

Service d'Anatomie Pathologique, Assistance Publique-Hôpitaux de Paris, Univeristé Paris-Saclay, Le Kremlin-Bicêtre, France.

Mojgan Asgari (M)

Oncopathology Research Center, Iran University of Medical Sciences, Tehran, Iran.
Hasheminejad Kidney Center, Iran University of Medical Sciences, Tehran, Iran.

Surasak Sangkhathat (S)

Translational Medicine Research Center, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand.

Worapat Attawettayanon (W)

Division of Urology, Department of Surgery, Faculty of Medicine, Prince of Songkla University, Hat Yai, Thailand.

Beata Świątkowska (B)

Department of Environmental Epidemiology, Nofer Institute of Occupational Medicine, Łódź, Poland.

Sonata Jarmalaite (S)

Laboratory of Genetic Diagnostic, National Cancer Institute, Vilnius, Lithuania.
Department of Botany and Genetics, Institute of Biosciences, Vilnius University, Vilnius, Lithuania.

Rasa Sabaliauskaite (R)

Laboratory of Genetic Diagnostic, National Cancer Institute, Vilnius, Lithuania.

Tatsuhiro Shibata (T)

Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo, Minato-ku, Japan.
Division of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Japan.

Akihiko Fukagawa (A)

Division of Cancer Genomics, National Cancer Center Research Institute, Chuo-ku, Japan.
Department of Pathology, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Japan.

Dana Mates (D)

Occupational Health and Toxicology Department, National Center for Environmental Risk Monitoring, National Institute of Public Health, Bucharest, Romania.

Viorel Jinga (V)

Urology Department, Carol Davila University of Medicine and Pharmacy, Prof. Dr. Th. Burghele Clinical Hospital, Bucharest, Romania.

Stefan Rascu (S)

Urology Department, Carol Davila University of Medicine and Pharmacy, Prof. Dr. Th. Burghele Clinical Hospital, Bucharest, Romania.

Mirjana Mijuskovic (M)

Clinic of Nephrology, Faculty of Medicine, Military Medical Academy, Belgrade, Serbia.

Slavisa Savic (S)

Department of Urology, University Hospital Dr D. Misovic Clinical Center, Belgrade, Serbia.

Sasa Milosavljevic (S)

International Organization for Cancer Prevention and Research, Belgrade, Serbia.

John M S Bartlett (JMS)

Cancer Research UK Edinburgh Centre, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK.

Monique Albert (M)

Centre for Biodiversity Genomics, University of Guelph, Guelph, Ontario, Canada.
Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Larry Phouthavongsy (L)

Ontario Tumour Bank, Ontario Institute for Cancer Research, Toronto, Ontario, Canada.

Patricia Ashton-Prolla (P)

Experimental Research Center, Genomic Medicine Laboratory, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Post-Graduate Program in Genetics and Molecular Biology, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Mariana R Botton (MR)

Transplant Immunology and Personalized Medicine Unit, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.

Brasil Silva Neto (B)

Service of Urology, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Post-Graduate Program in Medicine: Surgical Sciences, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil.

Stephania Martins Bezerra (SM)

Department of Anatomic Pathology, A. C. Camargo Cancer Center, São Paulo, Brazil.

Maria Paula Curado (MP)

Department of Epidemiology, A. C. Camargo Cancer Center, São Paulo, Brazil.

Stênio de Cássio Zequi (SC)

Department of Urology, A. C. Camargo Cancer Center, São Paulo, Brazil.
National Institute for Science and Technology in Oncogenomics and Therapeutic Innovation, A.C. Camargo Cancer Center, São Paulo, Brazil.
Latin American Renal Cancer Group (LARCG), São Paulo, Brazil.
Department of Surgery, Division of Urology, Sao Paulo Federal University (UNIFESP), São Paulo, Brazil.

Rui Manuel Reis (RM)

Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, Brazil.
Life and Health Sciences Research Institute (ICVS), School of Medicine, Minho University, Braga, Portugal.

Eliney Ferreira Faria (EF)

Faculdade Ciências Médicas de Minas Gerais, Belo Horizonte, Brazil.
Department of Urology, Barretos Cancer Hospital, Barretos, Brazil.

Nei Soares de Menezes (NS)

Department of Pathology, Barretos Cancer Hospital, Barretos, Brazil.

Renata Spagnoli Ferrari (RS)

Department of Urology, Barretos Cancer Hospital, Barretos, Brazil.

Rosamonde E Banks (RE)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.

Naveen S Vasudev (NS)

Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK.

David Zaridze (D)

Department of Clinical Epidemiology, N. N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia.

Anush Mukeriya (A)

Department of Clinical Epidemiology, N. N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia.

Oxana Shangina (O)

Department of Clinical Epidemiology, N. N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia.

Vsevolod Matveev (V)

Department of Urology, N. N. Blokhin National Medical Research Centre of Oncology, Moscow, Russia.

Lenka Foretova (L)

Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.

Marie Navratilova (M)

Department of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic.

Ivana Holcatova (I)

Institute of Public Health and Preventive Medicine, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic.
Department of Oncology, 2nd Faculty of Medicine, Charles University and Motol University Hospital, Prague, Czech Republic.

Anna Hornakova (A)

Institute of Hygiene and Epidemiology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.

Vladimir Janout (V)

Faculty of Health Sciences, Palacky University, Olomouc, Czech Republic.

Mark P Purdue (MP)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.

Nathaniel Rothman (N)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.

Stephen J Chanock (SJ)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.

Per Magne Ueland (PM)

Bevital AS, Bergen, Norway.

Mattias Johansson (M)

Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

James McKay (J)

Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Ghislaine Scelo (G)

Observational and Pragmatic Research Institute Pte Ltd, Singapore, Singapore.

Estelle Chanudet (E)

Department of Pathology, Radboud University Medical Centre, Nijmegen, Netherlands.

Laura Humphreys (L)

Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.

Ana Carolina de Carvalho (AC)

Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Sandra Perdomo (S)

Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France.

Ludmil B Alexandrov (LB)

Department of Cellular and Molecular Medicine, University of California San Diego, La Jolla, CA, USA.
Department of Bioengineering, University of California San Diego, La Jolla, CA, USA.
Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.

Michael R Stratton (MR)

Cancer, Ageing and Somatic Mutation, Wellcome Sanger Institute, Cambridge, UK.

Paul Brennan (P)

Genomic Epidemiology Branch, International Agency for Research on Cancer (IARC/WHO), Lyon, France. brennanp@iarc.who.int.

Classifications MeSH